Sociedad Americana de Hirudoterapia

Research progress on the treatment of diabetic nephropathy with leech and its active ingredients

Comprehensive review published in Frontiers in Endocrinology (2024)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewFarmacología salivalDesarrollo de fármacosTian F et al. · Frontiers in endocrinology, 2024

Abstract

Diabetic nephropathy (DN) is a major microvascular complication of diabetes and a common cause of chronic kidney disease. There is currently a lack of effective treatments for DN, and the prognosis for patients remains poor. Hirudin, one of the primary active components derived from leeches, demonstrates anti-coagulant, anti-fibrotic, anti-thrombotic, and anti-inflammatory properties, exhibiting significant protective effects on the kidneys. In recent years, there has been a surge of interest in studying the potential benefits of hirudin, especially in its role in the management of DN. This article delves into the mechanisms by which hirudin contributes to the treatment of DN and its clinical efficacy.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReviewResearch Support, Non-U.S. Gov't
Indexed MeSH termsAnimalsHumansDiabetic NephropathiesHirudinsKidneyMedicine, Chinese TraditionalLeechesDiabetes Mellitus

Resumen

Reviews preclinical evidence for medicinal leech and its active ingredients (hirudin variants, peptides) in treatment of diabetic nephropathy across multiple animal models.

Por qué esto importa para la hirudoterapia

This review article examines the mechanisms by which hirudin, identified as a primary active component derived from leeches with anti-coagulant, anti-fibrotic, anti-thrombotic, and anti-inflammatory properties, may contribute to the treatment of diabetic nephropathy and its clinical efficacy. It discusses the lack of effective current treatments for diabetic nephropathy and the growing interest in hirudin's renoprotective potential. For ASH's domain, this is directly relevant as it surveys hirudin's therapeutic relevance beyond anticoagulation, specifically for renal protection in diabetes. Caveat: the abstract provides no specific quantitative data, primary study results, or critical appraisal of evidence quality; as a narrative review, its conclusions cannot be independently verified from the abstract alone.

Citación

Research progress on the treatment of diabetic nephropathy with leech and its active ingredients.

Tian F et al. · Frontiers in endocrinology, 2024

DOI

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Salivary Gland SecretionAnti-Inflammatory MechanismsSalivary ComplexDrug PipelineDrug DevelopmentDirect Thrombin InhibitorsHirudinAnticoagulation CompoundsOtolaryngology

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.